Amantadine HydrochlorideThird Party Manufacturing in India

Amantadine Hydrochloride works by multiple neurochemical mechanisms, primarily functioning as a weak, non-competitive antagonist at the N-methyl-D-aspartate (NMDA) type of glutamate receptors.

By blocking these NMDA receptors, it reduces the excessive and abnormal transmission of glutamate in the striatum, which helps stabilize motor control signals. Furthermore, it stimulates the release of dopamine from pre-synaptic storage sites, inhibits dopamine reuptake, and increases the sensitivity of postsynaptic dopamine receptors. These combined actions effectively alleviate characteristic Parkinsonian symptoms including tremors, muscle rigidity, and bradykinesia. In addition to its dopaminergic actions, it blocks the M2 proton channel of the influenza A virus, preventing viral replication.

Unlike direct dopamine agonists, Amantadine Hydrochloride provides a unique dual mechanism that targets both glutamate and dopamine pathways, helping to manage motor fluctuations. It is widely prescribed and well-tolerated for patients experiencing early-stage Parkinson's disease, levodopa-induced dyskinesias, and drug-induced extrapyramidal reactions.

Therapeutic Uses

Amantadine Hydrochloride is prescribed for the treatment of:

• Parkinson's Disease: Used as monotherapy or adjunctive therapy with levodopa to manage idiopathic Parkinson's disease symptoms, improving patient mobility.
• Drug-Induced Extrapyramidal Reactions: Helps control involuntary movement disorders, motor restlessness, and tremors caused by antipsychotic medications.
• Levodopa-Induced Dyskinesia: Manages involuntary, jerky movements that occur as a complication of long-term levodopa therapy in advanced Parkinson's.
• Influenza A Viral Infection: Used for the prevention and treatment of respiratory tract infections caused by specific influenza A virus strains.

Why Manufacturers Choose Amantadine Hydrochloride

Amantadine Hydrochloride is a highly established drug on the WHO Model List of Essential Medicines, ensuring consistent demand globally. Its clinical versatility as both an antiparkinsonian treatment and an antiviral agent gives it a stable, year-round market profile. For pharmaceutical distributors, offering this molecule is critical for maintaining a complete neuropsychiatric portfolio. The molecule has high chemical stability, which simplifies formulation and packaging requirements for third-party manufacturers, allowing for longer shelf-life and cost-effective distribution.

This makes Amantadine Hydrochloride one of the most sought-after molecules for third party manufacturing in India, with consistent demand from neuropsychiatric PCD franchise operators and export-oriented companies.